Premier in diagnostics deal with DiaSys:
This article was originally published in Clinica
US group purchasing organisation Premier has signed a two-year deal to access part of DiaSys's line of diagnostics for its 1,600-member hospitals. The deal, signed in May 2002, covers a new class of products developed by Waterbury, Connecticut-based DiaSys, the R/S series lab workstations. The device monitors patients with cancer, kidney disease and expectant mothers. Microscopic urine testing is also available from the device. Premier, which is owned by 200 hospitals and healthcare systems, distributes $14 billion-worth of supplies and equipment to its members annually.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.